Cargando…
Intraprostatic Botulinum Neurotoxin Type A Injection for Benign Prostatic Hyperplasia—A Spotlight in Reality
Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. It inhibits the release of acetylcholine and other neurotransmitters from the nerve terminal. Botulinum toxin, specifically toxin type A (BoNT-A) has been used since the 1970s to reduce the muscular hypercontraction dis...
Autores principales: | Hsu, Yu-Chao, Wang, Hung-Jen, Chuang, Yao-Chi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885041/ https://www.ncbi.nlm.nih.gov/pubmed/27128942 http://dx.doi.org/10.3390/toxins8050126 |
Ejemplares similares
-
Intraprostatic Botulinum Toxin injection in patients
with benign prostatic enlargement
por: Ilie, CP, et al.
Publicado: (2009) -
Intraprostatic injection of botulinum toxin A: A promising treatment for patients with benign prostatic hyperplasia
por: Agrawal, S. K., et al.
Publicado: (2009) -
Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019) -
Intraprostatic Injection of Alcohol Gel for the Treatment of Benign Prostatic Hyperplasia: Preliminary Clinical Results
por: Larson, Benjamin T., et al.
Publicado: (2006) -
The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
por: Kwon, Young Kee, et al.
Publicado: (2010)